1 H NMR spectra were recorded with a Bruker Avance 300 MHz spectrometer at 300 K, using TMS as an internal standard. MS spectra were recorded on a Mariner Mass Spectrum (ESI). High resolution mass spectra were recorded using an Agilent Technologies LC/MSD TOF. All compounds were routinely checked by TLC and 1 H NMR. TLCs and preparative thin-layer chromatography were performed on silica gel GF/UV 254, and the chromatograms were conducted on silica gel (200-300 mesh, Merck) and visualized under UV light at 254 and 365 nm. All solvents were reagent grade and, when necessary, were purified and dried by standard methods. 4-Formylbenzoate 1, L-tryptophan 4, differently substituted primary amines 2a-d and aldehydes were commercially available. Compounds 5a-d and 4a-d were synthesized according to literature procedures. 1, 2 Solutions after reactions and extractions were concentrated using a rotary evaporator operating at a reduced pressure of ca. 20 Torr. Organic solutions were dried over anhydrous sodium sulfate. All compounds were of >95% purity determined by HPLC.
Methyl 4-((methylamino)methyl)benzoate (3a)
To a solution of methyl 4-formylbenzoate 1 (6.8 mmol, 1.12 g) in 15ml anhydrous tetrahydrofuran (THF) was added ethanol amine 2a (8.2 mmol, 0.50 g) and catalytic amount of HOAc.The reaction was stirred at room temperature for 5h. To the mixture was added sodium boron hydride (17.1 mmol, 0.65 g). After the reaction was completed, the solvent was removed under reduced pressure. The crude residue was dissolved in water and was adjusted by 2M HCl to pH = 3. The solution was washed with ethyl acetate (3 × 20 mL). The water layer was adjusted with 2M NaOH to pH = 11. The solution was extracted with ethyl acetate (3 × 20 mL). The organic phase was washed with brine and concentrated to give a yellow oil product 3a, yield 76%.
Methyl 4-((ethylamino)methyl)benzoate (3b) Compound 3b was synthesized from 4-formylbenzoate 1, ethanamine 2b, and sodium boron hydride, according to the synthetic procedure of 3a in a yield of 62%, yellow oil.
Methyl 4-((propylamino)methyl)benzoate (3c) Compound 3c was synthesized from 4-formylbenzoate 1, propan-1-amine 2c, and sodium boron hydride, according to the synthetic procedure of 3a in a yield of 62%, yellow oil.
Methyl 4-((butylamino)methyl)benzoate (3d) Compound 3f was synthesized from 4-formylbenzoate 1, butan-1-amine 2d, and sodium boron hydride, according to the synthetic procedure of 3a in a yield of 62%, yellow oil. MS (ESI) m/z = 222 [M+H] + . [3,4-b] indole-3-carboxamide (8a) To a solution of 6a (0.25 g, 1.2 mmol), EDCI (0.27 g, 1.44 mmol) and catalytic amount of DMAP in 10 mL anhydrous CH 2 Cl 2 , was added methyl 4-((methylamino)methyl)benzoate 3a (0.21 g, 1.2 mmol). The mixture was stirred at room temperature overnight. Then 20 mL of CH 2 Cl 2 was added and the mixture was washed with water (30 mL × 3) and brine. The organic phase was dried over anhydrous sodium sulfate, filtered and evaporated in vacuo, and the crude product was purified by column chromatography to give 7a, which was then dissolved in 3 mL anhydrous methanol, and poured into a solution of NH 2 OK (0.09 g, 4 mmol) in 3 mL of anhydrous methanol. The mixture was stirred for 10-15 h and the solvent was evaporated in vacuo. The residue was diluted with saturated NH 4 Cl aqueous solution, and then extracted with ethyl acetate (6 mL × 5). The organic layers were combined, dried over anhydrous Na 2 SO 4 and evaporated. The resulting residue was purified by column chromatography (eluting with EA followed by 20:1 CHCl 3 /MeOH followed by 10:1 CHCl 3 /MeOH) on silica gel to afford 8a as a pale yellow solid in a yield of 65%. Analytical data for 8a: 1 
N-(4-(Hydroxycarbamoyl)benzyl)-N-methyl-9H-pyrido

N-Ethyl-N-(4-(hydroxycarbamoyl)benzyl)-9H-pyrido[3,4-b]indole-3-carboxamide (8b)
Compound 8b was synthesized from 6a, methyl 4-((ethylamino)methyl)benzoate 3b, EDCI, and NH 2 OK, according to the synthetic procedure of 8a in a yield of 63%, a pale yellow solid. Analytical data for 8b: 1 
N-(4-(Hydroxycarbamoyl)benzyl)-N-propyl-9H-pyrido[3,4-b]indole-3-carboxamide (8c)
Compound 8c was synthesized from 6a, methyl 4-((propylamino)methyl)benzoate 3c, EDCI, and NH 2 OK, according to the synthetic procedure of 8a in a yield of 62%, a pale yellow solid. Analytical data for 8c: 1 [3,4-b] indole-3-carboxamide (8d) Compound 8d was synthesized from 6a, methyl 4-((butylamino)methyl)benzoate 3f, EDCI, and NH 2 OK, according to the synthetic procedure of 8a in a yield of 66%, a pale yellow solid. Analytical data for 8d: 1 
N-Butyl-N-(4-(hydroxycarbamoyl)benzyl)-9H-pyrido
N-Bytyl-N-(4-(hydroxycarbamoyl)benzyl)-9-methyl-9H-pyrido[3,4-b]indole-3-carboxamide (8h)
Compound 8h was synthesized from 6b, methyl 4-((butylamino)methyl)benzoate 3f, EDCI, and NH 2 OK, according to the synthetic procedure of 8a in a yield of 68%, a pale yellow solid. Analytical data for 8h: 1 [3,4-b] indole-3-carboxamide (8i) Compound 8i was synthesized from 6c, methyl 4-((methylamino)methyl)benzoate 3a, EDCI, and NH 2 OK, according to the synthetic procedure of 8a in a yield of 62%, a pale yellow solid. Analytical data for 8i: 1 [3,4-b] indole-3-carboxamide (8j) Compound 8j was synthesized from 6c, methyl 4-((ethylamino)methyl)benzoate 3b, EDCI, and NH 2 OK, according to the synthetic procedure of 8a in a yield of 62%, a pale yellow solid. Analytical data for 8j: 1 [3,4-b] indole-3-carboxamide (8k) Compound 8k was synthesized from 6c, methyl 4-((propylamino)methyl)benzoate 3c, EDCI, and NH 2 OK, according to the synthetic procedure of 8a in a yield of 62%, a pale yellow solid. Analytical data for 8k: 1 [3,4-b] indole-3-carboxamide (8l) Compound 8l was synthesized from 6c, methyl 4-((butylamino)methyl)benzoate 3d, EDCI, and NH 2 OK, according to the synthetic procedure of 8a in a yield of 62%, a pale yellow solid. Analytical data for 8l: 1 [3,4-b] indole-3-carboxamide(8m) Compound 8m was synthesized from 6d, methyl 4-((propylamino)methyl)benzoate 3c, EDCI, and NH 2 OK, according to the synthetic procedure of 8a in a yield of 62%, a pale yellow solid. Analytical data for 8m: 1 [3,4-b] indole-3-carboxamide (8n) Compound 8n was synthesized from 6d, methyl 4-((butylamino)methyl)benzoate 3d, EDCI, and NH 2 OK, according to the synthetic procedure of 8a in a yield of 62%, a pale yellow solid. Analytical data for 8n: 1 , and Hela cells were maintained in DMEM supplemented with 10% fetal bovine serum (Invitrogen), 100 units/ml of penicillin, and 0.1 µg/ml of streptomycin in a humid atmosphere incubator with 5% CO 2 at 37 °C. All cell lines were originally from the Shanghai Institute of Cell Biology (Shanghai, China). Cells were routinely subcultured twice weekly. PARP antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), monoclonal anti-actin antibody, and goat peroxidase-conjugated anti-rabbit IgG antibody, and goat peroxidase-conjugated antimouse IgG antibody were purchased from Sigma-Aldrich (St. Louis, MO). FITC-Annexin V and PI are from (BioVision). The chemiluminescence (ECL) kit was purchased from Thermo Fisher Scientific (Rockford, IL). Antibodies such as acetyl-H3, acetyl-tubulin, Bax, Bcl-2, and cleavedcaspase 3 are from Cell Signaling Technology (Danvers, MA).
N-(4-(Hydroxycarbamoyl)benzyl)-9-(4-methoxyphenyl)-N-methyl--9H-pyrido
N-Ethyl-N-(4-(hydroxycarbamoyl)benzyl)-9-(4-methoxyphenyl)-9H-pyrido
N-(4-(Hydroxycarbamoyl)benzyl)-9-(4-methoxyphenyl)-N-propyl-9H-pyrido
N-Butyl-N-(4-(hydroxycarbamoyl)benzyl)-9-(4-methoxyphenyl)-9H-pyrido
N-(4-(Hydroxycarbamoyl)benzyl)-9-(3-methoxyphenyl)-N-propyl-9H-pyrido
N-Butyl-N-(4-(hydroxycarbamoyl)benzyl)-9-(3-methoxyphenyl)-9H-pyrido
UV-visible absorption
